SCHEMBL5604600

SCHEMBL5604600

CCCC/C=C/NC(=O)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 7/20 0.58
CYP2C9 P11712 6/20 0.58
TSHR P16473 6/20 0.58
CYP2C19 P33261 6/20 0.58
CYP3A4 P08684 5/20 0.58
ALDH1A1 P00352 4/20 0.58
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
NAAA Q02083 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.50
MAPK1 P28482 1/20 0.48
TRPV1 Q8NER1 1/20 0.47
SOAT2 O75908 1/20 0.44
SOAT1 P35610 1/20 0.44
HDAC1 Q13547 2/20 0.44
CYP2D6 P10635 2/20 0.44
HDAC6 Q9UBN7 1/20 0.44
CES2 O00748 2/20 0.44
CES1 P23141 2/20 0.44
HDAC3 O15379 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6075048 1.00 CYP1A2 (0.58) CYP1A2CYP2C9TSHRCYP2C19CYP3A4
SCHEMBL8151739 0.94 NAAA (0.56) CYP1A2CYP2C9TSHRCYP2C19CYP3A4
SCHEMBL8151740 0.94 NAAA (0.56) CYP1A2CYP2C9TSHRCYP2C19CYP3A4
SCHEMBL1556345 0.83 NAAA (0.54) CYP1A2CYP2C9TSHRCYP2C19CYP3A4
SCHEMBL6551872 0.83 RAB9A (0.58) CYP1A2CYP2C9TSHRCYP2C19CYP3A4
SCHEMBL17188462 0.83 RAB9A (0.58) CYP1A2CYP2C9TSHRCYP2C19CYP3A4
SCHEMBL6551341 0.81 NPC1 (0.56) CYP1A2CYP2C9TSHRCYP2C19CYP3A4
SCHEMBL2237461 0.81 SMN1; SMN2 (0.52) CYP1A2CYP3A4ALDH1A1NPC1RAB9A
SCHEMBL4611015 0.80 NPC1 (0.54) CYP2C19ALDH1A1NPC1RAB9AHDAC1
SCHEMBL1416822 0.79 NAAA (0.57) CYP1A2CYP2C9TSHRCYP2C19CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1390340-B1 COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS MASSACHUSETTS INST TECHNOLOGY (US) 2017-03-01 EP disclosed
EP-1390340-B1 COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS MASSACHUSETTS INST TECHNOLOGY (US) 2017-03-01 EP disclosed
US-9067955-B2 Copper-catalyzed formation of carbon-heteroatom and carbon—carbon bonds MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2015-06-30 US disclosed
US-9067955-B2 Copper-catalyzed formation of carbon-heteroatom and carbon—carbon bonds MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2015-06-30 US disclosed
EP-1390340-A4 COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS MASSACHUSETTS INST TECHNOLOGY (US) 2007-07-25 EP disclosed
US-7115784-B2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2006-10-03 US disclosed
US-20050215794-A1 Copper-catalyzed formation of carbon heteroatom and carbon-carbon bonds NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2005-09-29 US disclosed
US-6867298-B2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2005-03-15 US disclosed
CN-1518534-A Copper-catalyzed carbon-heteroatom and carbon-carbon bond formation 麻省理工学院 2004-08-04 CN disclosed
US-6759554-B2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2004-07-06 US disclosed
EP-1390340-A1 COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2004-02-25 EP disclosed
US-20040019216-A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-01-29 US disclosed
WO-2002085838-A1 COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2002-10-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050215794-A1 Copper-catalyzed formation of carbon heteroatom and carbon-carbon bonds CBR3, ADH5, IDH1 CYP1A2 46/4885CYP2C9 287/4885TSHR 3230/4885
US-20040019216-A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds ADH5, CBR3, ALDH3A1 CYP1A2 40/4885CYP2C9 269/4885TSHR 3079/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.